Resources Contact Us Home
Modified factor VIII

Image Number 5 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Curable inks comprising surfactant-coated magnetic nanoparticles
Systems and/or methods for using air/wind power to charge/re-charge vehicle batteries
System and method for providing location and access network information support in a network environment
Multiplanar image displays and media formatted to provide 3D imagery without 3D glasses
Method for producing purified influenza virus antigen
Non-volatile semiconductor memory and data processing method in non-volatile semiconductor memory
Method and apparatus for charging a power pack of a portable electronic device
  Randomly Featured Patents
Multi-compartment refrigerator control algorithm for variable speed evaporator fan motor
Storage element and SRAM cell structures using vertical FETS controlled by adjacent junction bias through shallow trench isolation
Krill oil and method for manufacturing the same
Process for removing undesirable substances from electrical devices
Ceiling fan cleaning apparatus
Talking video games with parallel montage
Projector as an input and output device
Roof support for liquid metal cooled fast breeder nuclear reactor
Multilayer polyacrylonitrile film
Ignition timing controlling device and method